We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$148M
AUM Growth
+$2.71M
Cap. Flow
-$4.68M
Cap. Flow %
-3.17%
Top 10 Hldgs %
31.11%
Holding
140
New
3
Increased
17
Reduced
99
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 23.52%
2 Technology 12.84%
3 Financials 10.86%
4 Industrials 8.83%
5 Energy 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STT icon
26
State Street
STT
$50.6B
$1.71M 1.16%
25,488
-6,152
-19% -$405K
SPY icon
27
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$1.64M 1.11%
8,364
+1,764
+27% +$335K
ABT icon
28
Abbott
ABT
$181B
$1.57M 1.06%
38,350
-439
-1% -$17.2K
EXPD icon
29
Expeditors International
EXPD
$22B
$1.57M 1.06%
35,462
-745
-2% -$32K
MTB icon
30
M&T Bank
MTB
$35.8B
$1.55M 1.05%
12,517
-70
-0.6% -$8.53K
NVS icon
31
Novartis
NVS
$296B
$1.54M 1.04%
18,972
-558
-3% -$43.9K
GE icon
32
GE Aerospace
GE
$370B
$1.54M 1.04%
12,209
-219
-2% -$27.9K
LLL
33
DELISTED
L3 Technologies, Inc.
LLL
$1.53M 1.04%
12,691
-500
-4% -$59.4K
TEVA icon
34
Teva Pharmaceuticals
TEVA
$40.6B
$1.47M 1%
28,000
-750
-3% -$38.3K
TECH icon
35
Bio-Techne
TECH
$11.2B
$1.43M 0.97%
61,760
-2,880
-4% -$63.6K
BRK.A icon
36
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.33M 0.9%
7
VZ icon
37
Verizon
VZ
$193B
$1.26M 0.85%
25,718
+26
+0.1% +$1.26K
APA icon
38
APA Corp
APA
$12.9B
$1.17M 0.79%
11,624
-400
-3% -$36.2K
CHRW icon
39
C.H. Robinson
CHRW
$17.4B
$1.16M 0.79%
18,210
+45
+0.2% +$2.65K
NXGN
40
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$1.12M 0.76%
69,950
-200
-0.3% -$3.16K
BIDU icon
41
Baidu
BIDU
$36.8B
$1.08M 0.73%
5,780
-75
-1% -$12.3K
BDX icon
42
Becton Dickinson
BDX
$45.1B
$1.03M 0.7%
8,906
-154
-2% -$17.5K
NSC icon
43
Norfolk Southern
NSC
$74.7B
$1.02M 0.69%
9,875
WMT icon
44
Walmart Inc
WMT
$886B
$1.02M 0.69%
40,626
-300
-0.7% -$7.71K
DGX icon
45
Quest Diagnostics
DGX
$25.8B
$1M 0.68%
17,116
+320
+2% +$18.7K
CHL
46
DELISTED
China Mobile Limited
CHL
$971K 0.66%
19,975
-175
-0.9% -$8.39K
AMGN icon
47
Amgen
AMGN
$206B
$957K 0.65%
8,083
-265
-3% -$30.7K
DCM
48
DELISTED
NTT DOCOMO, Inc.
DCM
$947K 0.64%
55,400
-1,400
-2% -$22.8K
PAYX icon
49
Paychex
PAYX
$41.2B
$882K 0.6%
21,225
-5,648
-21% -$232K
CME icon
50
CME Group
CME
$96.6B
$867K 0.59%
12,215
-1,600
-12% -$113K

Similar funds

Roberts, Glore & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Roberts, Glore & Co held 140 positions worth $148M, up 1.9% from $145M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Roberts, Glore & Co withdrew a net $4.68M in Q2 2014, closing 4 positions and reducing 99 holdings. Its most notable exit was Rayonier, an estimated $250K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

Against the trend, Roberts, Glore & Co opened a new position in KINDER MORGAN ENER PNTRS L.P. worth $214K.

  • Roberts, Glore & Co's largest Q2 2014 buy was KINDER MORGAN ENER PNTRS L.P.: 2,600 shares worth $214K.
  • Roberts, Glore & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $335K increase.
  • Roberts, Glore & Co's biggest Q2 2014 reduction was State Street, cutting an estimated $405K.
  • Roberts, Glore & Co fully exited Rayonier in Q2 2014, selling an estimated $250K.
  • Roberts, Glore & Co's ten largest holdings make up 31% of its $148M portfolio in Q2 2014.
  • Roberts, Glore & Co opened 3 new positions and closed 4 in Q2 2014.
  • Roberts, Glore & Co's portfolio value rose 1.9% quarter-over-quarter to $148M.

Based on Roberts, Glore & Co's 13F filing for Q2 2014, filed 5 Aug 2014.